Clinical implications of leaks following left atrial appendage ligation with the LARIAT device. JACC Cardiovasc Interv. 2016;9(10):1051-1057. 458. Fauchier L, Cinaud A, Brigadeau F, et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial brillation. J Am Coll Cardiol. 2018;71(14):1528-1536. 459. Dukkipati SR, Kar S, Holmes DR, Jr., et al. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes [published online ahead of print May 11, 2018]. 090. 460. Aryana A, Singh SK, Singh SM, et al. Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization. Heart Rhythm. 2015;12(7):1431-1437. 461. Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008;52(11):924-929. 462. Healey JS, Crystal E, Lamy A, et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150(2):288- 293. 463. Whitlock RP, Vincent J, Blackall MH, et al. Left Atrial Appendage Occlusion Study II (LAAOS II). Can J Cardiol. 2013;29(11):1443-1447. 464. Boriani G, Bif M, Diemberger I, Cervi E, Martignani C. Peri- operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. Int J Clin Pract. 2011;65(3):236-239. 465. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-e350S. 466. Ruff CT, Ansell JE, Becker RC, et al. North American Thrombosis Forum, AF Action Initiative Consensus Document. Am J Med. 2016;129(suppl 5):S1-S29. 467. Aliot E, Breithardt G, Brugada J, et al. 